{
    "2023-03-31": {
        "Tax Effect Of Unusual Items": -182212.581345,
        "Tax Rate For Calcs": 0.303688,
        "Normalized EBITDA": 470300000.0,
        "Total Unusual Items": -600000.0,
        "Total Unusual Items Excluding Goodwill": -600000.0,
        "Net Income From Continuing Operation Net Minority Interest": 224700000.0,
        "Reconciled Depreciation": 730000000.0,
        "Reconciled Cost Of Revenue": 2186900000.0,
        "EBIT": 469700000.0,
        "Net Interest Income": -147000000.0,
        "Interest Expense": 147000000.0,
        "Normalized Income": 225117787.418655,
        "Net Income From Continuing And Discontinued Operation": 224700000.0,
        "Total Expenses": 3328700000.0,
        "Total Operating Income As Reported": 399800000.0,
        "Diluted Average Shares": 1205600000.0,
        "Basic Average Shares": 1202500000.0,
        "Diluted EPS": 0.19,
        "Basic EPS": 0.19,
        "Diluted NI Availto Com Stockholders": 224700000.0,
        "Net Income Common Stockholders": 224700000.0,
        "Net Income": 224700000.0,
        "Net Income Including Noncontrolling Interests": 224700000.0,
        "Net Income Continuous Operations": 224700000.0,
        "Tax Provision": 98000000.0,
        "Pretax Income": 322700000.0,
        "Other Income Expense": 69300000.0,
        "Other Non Operating Income Expenses": 69900000.0,
        "Special Income Charges": -600000.0,
        "Other Special Charges": 600000.0,
        "Restructuring And Mergern Acquisition": 1500000.0,
        "Net Non Operating Interest Income Expense": -147000000.0,
        "Interest Expense Non Operating": 147000000.0,
        "Operating Income": 400400000.0,
        "Operating Expense": 1141800000.0,
        "Research And Development": 182900000.0,
        "Selling General And Administration": 958900000.0,
        "Gross Profit": 1542200000.0,
        "Cost Of Revenue": 2186900000.0,
        "Total Revenue": 3729100000.0,
        "Operating Revenue": 3719100000.0
    },
    "2022-12-31": {
        "Tax Effect Of Unusual Items": -4416000.0,
        "Tax Rate For Calcs": 0.16,
        "Normalized EBITDA": 1643600000.0,
        "Total Unusual Items": -27600000.0,
        "Total Unusual Items Excluding Goodwill": -27600000.0,
        "Net Income From Continuing Operation Net Minority Interest": 1011200000.0,
        "Reconciled Depreciation": 869800000.0,
        "Reconciled Cost Of Revenue": 2601900000.0,
        "EBIT": 1616000000.0,
        "Net Interest Income": -147100000.0,
        "Interest Expense": 147100000.0,
        "Normalized Income": 1034384000.0,
        "Net Income From Continuing And Discontinued Operation": 1011200000.0,
        "Total Expenses": 4049700000.0,
        "Total Operating Income As Reported": -201300000.0,
        "Diluted Average Shares": 1221400000.0,
        "Basic Average Shares": 1213100000.0,
        "Diluted EPS": 0.83,
        "Basic EPS": 0.83,
        "Diluted NI Availto Com Stockholders": 1011200000.0,
        "Net Income Common Stockholders": 1011200000.0,
        "Net Income": 1011200000.0,
        "Net Income Including Noncontrolling Interests": 1011200000.0,
        "Net Income Continuous Operations": 1011200000.0,
        "Tax Provision": 457700000.0,
        "Pretax Income": 1468900000.0,
        "Other Income Expense": 1789700000.0,
        "Other Non Operating Income Expenses": 1817300000.0,
        "Special Income Charges": -27600000.0,
        "Other Special Charges": 27600000.0,
        "Restructuring And Mergern Acquisition": 2000000.0,
        "Net Non Operating Interest Income Expense": -147100000.0,
        "Interest Expense Non Operating": 147100000.0,
        "Operating Income": -173700000.0,
        "Operating Expense": 1447800000.0,
        "Research And Development": 182400000.0,
        "Selling General And Administration": 1265400000.0,
        "Gross Profit": 1274100000.0,
        "Cost Of Revenue": 2601900000.0,
        "Total Revenue": 3876000000.0,
        "Operating Revenue": 3867100000.0
    },
    "2022-09-30": {
        "Tax Effect Of Unusual Items": 624000.0,
        "Tax Rate For Calcs": 0.16,
        "Normalized EBITDA": 576800000.0,
        "Total Unusual Items": 3900000.0,
        "Total Unusual Items Excluding Goodwill": 3900000.0,
        "Net Income From Continuing Operation Net Minority Interest": 354300000.0,
        "Reconciled Depreciation": 699500000.0,
        "Reconciled Cost Of Revenue": 2329800000.0,
        "EBIT": 580700000.0,
        "Net Interest Income": -153200000.0,
        "Interest Expense": 153200000.0,
        "Normalized Income": 351024000.0,
        "Net Income From Continuing And Discontinued Operation": 354300000.0,
        "Total Expenses": 3522000000.0,
        "Total Operating Income As Reported": 560100000.0,
        "Diluted Average Shares": 1218100000.0,
        "Basic Average Shares": 1212500000.0,
        "Diluted EPS": 0.29,
        "Basic EPS": 0.29,
        "Diluted NI Availto Com Stockholders": 354300000.0,
        "Net Income Common Stockholders": 354300000.0,
        "Net Income": 354300000.0,
        "Net Income Including Noncontrolling Interests": 354300000.0,
        "Net Income Continuous Operations": 354300000.0,
        "Tax Provision": 73200000.0,
        "Pretax Income": 427500000.0,
        "Other Income Expense": 24500000.0,
        "Other Non Operating Income Expenses": 20600000.0,
        "Special Income Charges": 3900000.0,
        "Other Special Charges": -3900000.0,
        "Restructuring And Mergern Acquisition": -4500000.0,
        "Net Non Operating Interest Income Expense": -153200000.0,
        "Interest Expense Non Operating": 153200000.0,
        "Operating Income": 556200000.0,
        "Operating Expense": 1192200000.0,
        "Research And Development": 174900000.0,
        "Selling General And Administration": 1017300000.0,
        "Gross Profit": 1748400000.0,
        "Cost Of Revenue": 2329800000.0,
        "Total Revenue": 4078200000.0,
        "Operating Revenue": 4067400000.0
    },
    "2022-06-30": {
        "Tax Effect Of Unusual Items": -1624100.0,
        "Tax Rate For Calcs": 0.149,
        "Normalized EBITDA": 546100000.0,
        "Total Unusual Items": -10900000.0,
        "Total Unusual Items Excluding Goodwill": -10900000.0,
        "Net Income From Continuing Operation Net Minority Interest": 313900000.0,
        "Reconciled Depreciation": 722300000.0,
        "Reconciled Cost Of Revenue": 2413500000.0,
        "EBIT": 535200000.0,
        "Net Interest Income": -145900000.0,
        "Interest Expense": 145900000.0,
        "Normalized Income": 323175900.0,
        "Net Income From Continuing And Discontinued Operation": 313900000.0,
        "Total Expenses": 3557200000.0,
        "Total Operating Income As Reported": 548700000.0,
        "Diluted Average Shares": 1217100000.0,
        "Basic Average Shares": 1212300000.0,
        "Diluted EPS": 0.26,
        "Basic EPS": 0.26,
        "Diluted NI Availto Com Stockholders": 313900000.0,
        "Net Income Common Stockholders": 313900000.0,
        "Net Income": 313900000.0,
        "Net Income Including Noncontrolling Interests": 313900000.0,
        "Net Income Continuous Operations": 313900000.0,
        "Tax Provision": 75400000.0,
        "Pretax Income": 389300000.0,
        "Other Income Expense": -24400000.0,
        "Other Non Operating Income Expenses": -13500000.0,
        "Special Income Charges": -10900000.0,
        "Other Special Charges": 10900000.0,
        "Restructuring And Mergern Acquisition": 1300000.0,
        "Net Non Operating Interest Income Expense": -145900000.0,
        "Interest Expense Non Operating": 145900000.0,
        "Operating Income": 559600000.0,
        "Operating Expense": 1143700000.0,
        "Research And Development": 162600000.0,
        "Selling General And Administration": 981100000.0,
        "Gross Profit": 1703300000.0,
        "Cost Of Revenue": 2413500000.0,
        "Total Revenue": 4116800000.0,
        "Operating Revenue": 4105400000.0
    }
}